Smith Graham & Co Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $5.94M | Buy |
|
|||||
|
2023
Q3 | $3.71M | Sell |
|
|||||
|
2023
Q2 | $4.5M | Sell |
|
|||||
|
2023
Q1 | $4.79M | Sell |
|
|||||
|
2022
Q4 | $4.37M | Sell |
|
|||||
|
2022
Q3 | $7.39M | Sell |
|
|||||
|
2022
Q2 | $7.67M | Sell |
|
|||||
|
2022
Q1 | $9.77M | Sell |
|
|||||
|
2021
Q4 | $13.5M | Sell |
|
|||||
|
2021
Q3 | $13.2M | Sell |
|
|||||
|
2021
Q2 | $12.9M | Sell |
|
|||||
|
2021
Q1 | $15.5M | Buy |
|
|||||
|
2020
Q4 | $9.7M | Buy |
|
|||||
|
2020
Q3 | $7.03M | Buy |
|